Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuropsychiatric lupus.

J G Hanly1

  • 1Division of Rheumatology, Queen Elizabeth II Health Sciences Center, 310 Bethune Building, Halifax, Nova Scotia, B3H 2Y9, Canada. jhanly@is.dal.ca

Current Rheumatology Reports
|May 16, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: A systematic review.

Seminars in arthritis and rheumatism·2020
Same author

The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients.

Lupus·2017
Same author

Avoiding diagnostic pitfalls in neuropsychiatric lupus: the importance of attribution.

Lupus·2017
Same author

Breast cancer in systemic lupus.

Lupus·2016
Same author

Treatment pathways in an inception lupus cohort over the first three years.

Lupus·2016
Same author

International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA antibodies.

Lupus·2016
Same journal

Type I Interferonopathies: Fifteen Years On, From Concept to Therapeutic Perspectives.

Current rheumatology reports·2026
Same journal

Intensive Care Management of ANCA-associated Vasculitides: a Narrative Review.

Current rheumatology reports·2026
Same journal

The Role of Musculoskeletal Ultrasound in Psoriatic Arthritis: From Preclinical Detection to Treatment Monitoring.

Current rheumatology reports·2026
Same journal

Correction to: Is Gout and Autoinflammatory Disease?

Current rheumatology reports·2026
Same journal

Risks and Management of Glucocorticoid Therapy for Patients with Rheumatic Disease Having Surgery.

Current rheumatology reports·2026
Same journal

Perioperative Management Considerations for Patients with Systemic Lupus Erythematosus.

Current rheumatology reports·2026
See all related articles

Neuropsychiatric lupus erythematosus (NP-SLE) presents diverse challenges. Standardized criteria and advanced imaging aid diagnosis, but effective treatments for cognitive impairment require further research.

Area of Science:

  • Rheumatology
  • Neurology
  • Immunology

Background:

  • Neuropsychiatric (NP) manifestations in systemic lupus erythematosus (SLE) are complex and challenging for clinicians.
  • Prevalence of NP-SLE varies widely (14-75%), complicating patient classification and research.

Purpose of the Study:

  • To review the diagnostic and therapeutic challenges of NP-SLE.
  • To highlight the impact of new nomenclature, imaging, and neuropsychometric techniques.

Main Methods:

  • Literature review of NP-SLE manifestations, etiology, diagnosis, and management.
  • Discussion of recent advancements in classification, imaging, and cognitive assessment.

Main Results:

  • Standardized nomenclature and diagnostic criteria for 19 NP-SLE syndromes have been introduced.

Related Experiment Videos

  • Advanced imaging and neuropsychometric techniques reveal high rates of cognitive impairment in SLE patients.
  • Etiology is multifactorial, involving microangiopathy, autoantibodies, and cytokine production.
  • Conclusions:

    • Standardized approaches are improving NP-SLE classification and research potential.
    • Multicenter studies are crucial for advancing prognosis and management strategies.
    • Further research is needed to establish evidence-based therapeutic guidelines for NP-SLE.